BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Neuron
,
Holistic medicine
,
Doxycycline
,
rs2476601
,
MDM2
,
glucose metabolic process
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
ras oncogen
Summary
General Info
Curated Studies
Most Correlated Studies
Lung fibroblasts expressing oncogenic ras and shRNA against ERK2
Keratinocytes transduced with oncogenic v-Ras and treated with an IL1 receptor antagonist
Lung fibroblast IMR-90 ER-RAS cells with HRAS G12V oncogene-induced senescence and ARID1B shRNA
Skin tissue from IQGAP1 knockout mice after acute oncogenic RAS activation
Duodenum tissue from high-fat diet fed mice expressing activated K-ras
Explore Curated Studies Results
Literature
Most Relevant Literature
Overexpression of wild type RRAS2, without oncogenic mutations, drives chronic lymphocytic leukemia.
Specific Disruption of Ras2 CAAX Proteolysis Alters Its Localization and Function.
Active Ras2 in mitochondria promotes regulated cell death in a cAMP/PKA pathway-dependent manner in …
Autophagy Stimulus-Dependent Role of the Small GTPase Ras2 in Peroxisome Degradation.
A fluorescence-electrochemiluminescence dual-mode sensor based on a "switch" system for highly selec…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA …
Exploratory Study of TG02-treatment as Monotherapy or in Combination With Pembrolizumab to Assess Sa…
First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/…
Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRC
A Trial to Compare Oxaliplatin, Folinic Acid (FA) and 5-Fluorouracil (5FU) Combination Chemotherapy …
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ